These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26261087)

  • 1. Deep transcriptome profiling of clinical Klebsiella pneumoniae isolates reveals strain and sequence type-specific adaptation.
    Bruchmann S; Muthukumarasamy U; Pohl S; Preusse M; Bielecka A; Nicolai T; Hamann I; Hillert R; Kola A; Gastmeier P; Eckweiler D; Häussler S
    Environ Microbiol; 2015 Nov; 17(11):4690-710. PubMed ID: 26261087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Two-Year Surveillance in Five Colombian Tertiary Care Hospitals Reveals High Frequency of Non-CG258 Clones of Carbapenem-Resistant Klebsiella pneumoniae with Distinct Clinical Characteristics.
    Ocampo AM; Chen L; Cienfuegos AV; Roncancio G; Chavda KD; Kreiswirth BN; Jiménez JN
    Antimicrob Agents Chemother; 2016 Jan; 60(1):332-42. PubMed ID: 26503660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypical and molecular assessment of the virulence potential of KPC-3-producing Klebsiella pneumoniae ST392 clinical isolates.
    D'Apolito D; Arena F; Conte V; De Angelis LH; Di Mento G; Carreca AP; Cuscino N; Russelli G; Iannolo G; Barbera F; Pasqua S; Monaco F; Cardinale F; Rossolini GM; Conaldi PG; Douradinha B
    Microbiol Res; 2020 Nov; 240():126551. PubMed ID: 32652494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring microevolution of OXA-48-producing Klebsiella pneumoniae ST147 in a hospital setting by SMRT sequencing.
    Zautner AE; Bunk B; Pfeifer Y; Spröer C; Reichard U; Eiffert H; Scheithauer S; Groß U; Overmann J; Bohne W
    J Antimicrob Chemother; 2017 Oct; 72(10):2737-2744. PubMed ID: 29091199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of ST258 Colistin-Resistant, blaKPC-Producing Klebsiella pneumoniae in a Greek Hospital.
    Mavroidi A; Katsiari M; Likousi S; Palla E; Roussou Z; Nikolaou C; Maguina A; Platsouka ED
    Microb Drug Resist; 2016 Jul; 22(5):392-8. PubMed ID: 26840950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal dissemination of multilocus sequence type 11 Klebsiella pneumoniae carbapenemase - producing K. pneumoniae in a Chinese teaching hospital.
    Sun K; Chen X; Li C; Yu Z; Zhou Q; Yan Y
    APMIS; 2015 Feb; 123(2):123-7. PubMed ID: 25257726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of VIM-1 and IMP-1 genes in Klebsiella pneumoniae and relationship with biofilm formation.
    Khodadadian R; Rahdar HA; Javadi A; Safari M; Khorshidi A
    Microb Pathog; 2018 Feb; 115():25-30. PubMed ID: 29248513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of a New Variant OXA-204 and OXA-48 Carbapenemases Plasmids Encoded in Klebsiella pneumoniae Clinical Isolates in Tunisia.
    Ouertani R; Ben Jomàa-Jemili M; Gharsa H; Limelette A; Guillard T; Brasme L; de Champs C; Chouchani C
    Microb Drug Resist; 2018 Mar; 24(2):142-149. PubMed ID: 28737463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of virulence between matt and mucoid colonies of Klebsiella pneumoniae coproducing NDM-1 and OXA-232 isolated from a single patient.
    Lee H; Baek JY; Kim SY; Jo H; Kang K; Ko JH; Cho SY; Chung DR; Peck KR; Song JH; Ko KS
    J Microbiol; 2018 Sep; 56(9):665-672. PubMed ID: 30141159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Characterization of Imipenem-Resistant Klebsiella pneumoniae and Susceptible Klebsiella variicola Isolates Obtained from the Same Patient.
    Garza-Ramos U; Moreno-Dominguez S; Hernández-Castro R; Silva-Sanchez J; Barrios H; Reyna-Flores F; Sanchez-Perez A; Carrillo-Casas EM; Sanchez-León MC; Moncada-Barron D
    Microb Drug Resist; 2016 Apr; 22(3):179-84. PubMed ID: 26571390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
    Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capsular Polysaccharide Types and Virulence-Related Traits of Epidemic KPC-Producing Klebsiella pneumoniae Isolates in a Chinese University Hospital.
    Liu Y; Liu PP; Wang LH; Wei DD; Wan LG; Zhang W
    Microb Drug Resist; 2017 Oct; 23(7):901-907. PubMed ID: 28437231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KPC-Producing Klebsiella pneumoniae Isolates in Croatia: A Nationwide Survey.
    Jelic M; Butic I; Plecko V; Cipris I; Jajic I; Bejuk D; Koscak I; Marinkovic S; Pal MP; Andrasevic AT
    Microb Drug Resist; 2016 Dec; 22(8):662-667. PubMed ID: 26709956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal Dissemination of OXA-232 Carbapenemase-Producing Klebsiella pneumoniae in Neonates.
    Yin D; Dong D; Li K; Zhang L; Liang J; Yang Y; Wu N; Bao Y; Wang C; Hu F
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Update of the Evolving Epidemic of blaKPC Carrying Klebsiella pneumoniae in Sicily, Italy, 2014: Emergence of Multiple Non-ST258 Clones.
    Bonura C; Giuffrè M; Aleo A; Fasciana T; Di Bernardo F; Stampone T; Giammanco A; ; Palma DM; Mammina C
    PLoS One; 2015; 10(7):e0132936. PubMed ID: 26177547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Implications of Genomic Adaptation and Evolution of Carbapenem-Resistant Klebsiella pneumoniae.
    Gomez-Simmonds A; Uhlemann AC
    J Infect Dis; 2017 Feb; 215(suppl_1):S18-S27. PubMed ID: 28375514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
    Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Resistance Mechanisms on the Inoculum Effect of Carbapenem in Klebsiella pneumoniae Isolates with Borderline Carbapenem Resistance.
    Adler A; Ben-Dalak M; Chmelnitsky I; Carmeli Y
    Antimicrob Agents Chemother; 2015 Aug; 59(8):5014-7. PubMed ID: 25987630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colistin Resistance in KPC-2- and SHV-5-Producing Klebsiella pneumoniae Clinical Isolates in Bulgaria.
    Savov E; Todorova I; Politi L; Trifonova A; Borisova M; Kioseva E; Tsakris A
    Chemotherapy; 2017; 62(6):339-342. PubMed ID: 28738348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Balkan region: NDM-1-producing Klebsiella pneumoniae ST11 clonal strain causing outbreaks in Greece.
    Voulgari E; Gartzonika C; Vrioni G; Politi L; Priavali E; Levidiotou-Stefanou S; Tsakris A
    J Antimicrob Chemother; 2014 Aug; 69(8):2091-7. PubMed ID: 24739146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.